REDMOND, Wash--Jan. 13, 2003--SCOLR, Inc. (OTCBB:SCLL) announced the successful introduction of its patent-pending ReHydraid(TM) Low-Osmolality Sports Drink formulation at the SupplySide West Trade Show held in Las Vegas, Nevada. SupplySide West was the first unveiling of ReHydraid's Ready-to-Drink version.
ReHydraid(TM) was developed by SCOLR, Inc. to provide the benefit of immediate rehydration to high performance athletes before, during and after competition. The unique low osmolality formulation, consisting of carbohydrates, electrolytes and other proprietary ingredients, allows the beverage to be more rapidly absorbed by the body at a faster rate than most competitive sports drinks.
Osmolality measures how fast a liquid will be absorbed into the body. In order for water to be quickly transferred from the digestive system into the bloodstream, the liquid must have an osmolality lower than that of the blood itself (which averages 280 - 300 mOsm/kg). Depending on the formulation, ReHydraid(TM) has an osmolality from 140 to 240 mOsm/kg. Other leading sports beverages have been shown to have osmolalities greater than 330 mOsm/kg. A new study published in the April 2002 issue of Medicine & Science in Sports & Exercise shows that athletes can stave off fatigue 37% longer if they consume sports drinks.
According to Steven Moger, Vice President of Operations for SCOLR, "There is increasing demand for a rehydration beverage that can be used during a strenuous event without causing gastric upset. As a result of the positive interest and response generated at SupplySide West, we are currently shipping samples of ReHydraid(TM) to qualified licensees who have indicated a desire to test the product on a larger scale. ReHydraid(TM) is currently being marketed as a bulk powder formulation. Given the large number of requests from potential licensees for a ready-to-drink version, we produced a small production run of liquid ReHydraid(TM) at TalkingRain of Preston, Washington. More than 90% of the U.S. market prefers ready-to-drink over mixing powders. Companies licensing the drink will have the option of offering the drink in pouches or to engage a local bottling facility to produce their product."
Stephen J. Turner, Director of Product Development for SCOLR stated, "The ingredients we selected for ReHydraid(TM) drink replace essential elements and energy sources to aid the athlete in performance. This drink facilitates rapid hydration while delivering a good complement of beneficial electrolytes and carbohydrates so that fatigue and dehydration during the activity are minimized. We believe consumers will find that they have few available options if they are seeking a rehydration drink that can be consumed during the activity, which is necessary to maintain adequate hydration and stave off fatigue. Drinks with higher osmolality have been shown to cause cramping and gastric distress. This is mainly due to longer residence times in the stomach. As ReHydraid(TM) is a third-generation drink formulated by SCOLR, we believe that our expertise in this field has resulted in a great-tasting, beneficial drink that will be appreciated by 'weekend-warriors' and high performance athletes alike."
Based in Redmond, Washington, SCOLR, Inc. (formerly Nutraceutix, Inc.) is a biopharmaceutical company leveraging specialized knowledge, proprietary and patented products and technologies, such as the patented CDT(TM) Controlled Delivery Technology platform, to introduce distinctive and novel OTC products, prescription drugs and dietary supplements. SCOLR currently operates in two business segments -- drug delivery and nutraceuticals. For more information on SCOLR, please call 1-800/548-3222 or visit http://www.SCOLR.com/.
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 37A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the Company's ability to access sufficient capital to execute its business plans, its ability to continue to successfully market and provide its products and services and maintain their effectiveness, the continuation of the arrangements with the Company's product development partners, the ability of the Company to meet its financial projections, and general economic conditions. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update or revise forward-looking statements whether as a result of new information or otherwise.